University Clinic Heidelberg

Heidelberg 69120

1 studies enrolling now · 4 studies all time

What they study most

Advanced Cholangiocarcinoma, Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease (COPD), FGFR2 Gene Mutation, Melanoma, Melanoma (Skin), Melanoma Stage III, Melanoma Stage IV

Studies at this site

• A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD) — Recruiting now
• A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease — Running, not enrolling
• Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations — Stopped early
• Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence — Stopped early